NCT01515969 2016-07-12
Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)
Stanford University
Phase 1 Terminated
Clinical Trials
3 trialsNCT00633724 2013-08-15
Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer
Fukushima Medical University
Phase 1 Completed
NCT00874588 2013-08-15
Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer
Fukushima Medical University
Phase 1 Completed